Treatment of Galactorrhea
For symptomatic galactorrhea due to prolactinomas or idiopathic hyperprolactinemia, cabergoline is the first-line treatment, with doses ranging from 0.25-3 mg weekly, achieving galactorrhea resolution in 86% of patients. 1
Treatment Algorithm Based on Underlying Cause
1. Prolactinoma-Associated Galactorrhea (Micro- or Macroadenoma)
Dopamine agonist therapy is strongly recommended, specifically cabergoline over bromocriptine due to superior efficacy and tolerability 1. The evidence shows:
- Galactorrhea resolution: 86% (range 33-100%)
- Prolactin normalization: 95% in microadenomas, 77-92% in macroadenomas
- Dosing: Start 0.25 mg weekly, titrate up to 0.25-3 mg/week (occasionally up to 11 mg/week for resistant cases) 1
Cabergoline's superiority stems from higher dopamine receptor affinity, fewer side effects, and better compliance compared to bromocriptine 1. While bromocriptine remains an option (especially for fertility due to longer safety data), cabergoline achieves 90% tumor shrinkage versus 50% with bromocriptine 1.
Follow-up protocol 1:
- Check prolactin monthly initially to guide dose titration
- Repeat MRI at 1 year (or 3 months for macroadenomas)
- Monitor for persistent galactorrhea despite normalized prolactin
- Assess bone density if prolonged hypogonadism occurred
2. Medication-Induced Galactorrhea
First step: Discontinue the offending medication if clinically feasible 1. Common culprits include antipsychotics (especially risperidone with highest risk), antidepressants, metoclopramide, and hormone-related drugs 2, 3.
If discontinuation is not possible:
- Asymptomatic patients: No treatment needed 1
- Symptomatic with hypogonadism/low bone mass: Consider estrogen or testosterone replacement 1
- Dopamine agonist use is controversial in antipsychotic-induced cases—only 75% respond, and there's risk of psychosis exacerbation. Use cautiously in consultation with psychiatry 1
3. Idiopathic Galactorrhea (Normal Prolactin)
If galactorrhea is not bothersome: Reassurance only—no treatment required 4. This is a critical point often overlooked.
If bothersome: Short course of low-dose dopamine agonist (cabergoline 0.25-0.5 mg weekly) typically resolves symptoms 4.
4. Microprolactinoma with Asymptomatic Galactorrhea
Treatment is not recommended for asymptomatic patients with microprolactinomas, as these rarely grow 1.
For premenopausal women with amenorrhea from microprolactinoma who don't desire pregnancy: Either dopamine agonist OR oral contraceptives are acceptable options 1. Oral contraceptives are less expensive with fewer side effects, though amenorrhea won't serve as a marker for disease recurrence on this therapy.
Critical Pitfalls to Avoid
1. Attributing all galactorrhea to medication/benign causes: While rare, persistent unilateral galactorrhea with abnormal imaging requires tissue diagnosis to exclude malignancy, even in patients on prolactin-elevating medications 5. Standard core biopsy may miss diffuse DCIS—consider vacuum-assisted biopsy if imaging remains suspicious.
2. Treating asymptomatic medication-induced hyperprolactinemia: This adds unnecessary cost, side effects, and potential drug interactions without improving outcomes 1.
3. Using bromocriptine when cabergoline is available: Unless pregnancy is imminent (bromocriptine has longer safety data in pregnancy) or cost is prohibitive, cabergoline's superior efficacy and tolerability make it the clear choice 1, 6.
4. Missing secondary causes: Always check pregnancy test, TSH, and renal function before attributing galactorrhea to prolactinoma 6, 4. Hypothyroidism and chronic renal failure can cause hyperprolactinemia.
5. Inadequate dose escalation: If standard doses fail, increase to maximal tolerable doses before considering surgery 1. Some patients require up to 11 mg/week cabergoline.
When Surgery is Indicated
Transsphenoidal surgery is reserved for 6, 7:
- Dopamine agonist resistance despite maximal tolerable doses
- Intolerance to all dopamine agonists
- Patient preference after informed discussion
- Macroadenomas with visual field defects requiring urgent decompression
Surgery achieves long-term prolactin normalization in only 53% of cases, making medical therapy strongly preferred 1.